The US government and federal agencies are taking many initiatives to stop the epidemic. However, Facebook recently received critical warnings due to its negative role in opioid addiction. The social media giant reportedly announced that users who attempt to purchase opioids or locate addiction treatments will be redirected to federal crisis helpline information.
Scott Gottlieb, FDA Commissioner is looking for help from Facebook and Twitter to slow down the unauthorized opioid sales in the US. Gottlieb invited the two social media giants, among others, to participate in the FDA Online Opioid Summit which is set for June 27.
According to the FDA, if the antidote drugs are used on a patient, they could suffer from “allergic reactions, local irritation” and a wide number of cardiovascular issues, including restriction of blood supply to tissues. The FDA stated that there has not yet been any reports of patient harm from Naloxone.
In November, FDA’s device center will select which app is welcomed into the program, and the selected will have amplified interactions with FDA during the progress of their products. FDA will grant the advanced device nomination to products that meet the permitted criteria without requiring a separate application.
Recent innovations from global device makers like Abbott to smaller specialists such as Nevro Corp. made the implants more powerful and effective. Combined with a national crackdown on narcotics and wanton pain pill prescriptions, they are spurring demand for implants.
The team found that most participants opted to use opioids during the first three days following discharge from the emergency department and that on average, patients took just six pills, despite being given 21.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.